01|09|26

The Omnichannel Renaissance: What’s Next for Pharma in 2026? 

The life sciences industry is entering a new era. In a recent article penned for Med Ad News, Dan Gandor, EVP of Omnichannel Strategy, coined this the “Omnichannel Renaissance.”  

12|29|25

AI’s Next Big Move: Why Pharma Marketers Should Pay Attention

Artificial intelligence is changing the way people interact online, and the pace of innovation is accelerating. Just a few years ago, generative AI was a novelty. Today, platforms such as ChatGPT have become essential tools for millions, shaping how information is shared and decisions are made. At EVERSANA INTOUCH, we’re closely monitoring the next phase […]

12|22|25

DHC Monthly: What Pharma Marketers Should Act On for 2026 

The Digital Health Coalition’s December newsletter spotlights year‑end trends and predictions for 2026, featuring insights 18 industry leaders including Susan Perlbachs and Dan Gandor. Read the blog to learn about their key perspectives for 2026.

12|18|25

Beyond the Abstract: Four Converging Trends from ASH 2025

The American Society of Hematology (ASH) Annual Meeting is more than a forum for groundbreaking science; it is a barometer for the future of oncology. The key takeaways from ASH 2025 signal a fundamental shift in the hematologic cancer landscape, driven by a convergence of powerful forces. Download the POV to learn more.

12|18|25

Balancing Global Consistency and Local Nuance in Pharma Brand Strategy 

Creating a brand that resonates across markets while maintaining a strong global identity is one of pharma’s most persistent challenges. According to Susan Perlbachs and John Kenny solving this tension requires a shift in how marketers generate insight, make decisions and adapt creative to cultural nuance.

12|17|25

Cut Through the Noise: Creative Strategy in the Age of AI

In a recent webinar, hosted by DTC Perspectives, Dan Gandor, EVP, Head of Omnichannel & Digital Transformation and John Kenny, Chief Strategy Officer joined Richard Palizzolo, Executive Director, CX & Advanced Commercial Capabilities at Sobi to explore the evolving landscape of creative strategy in the age of AI. 

12|08|25

Leading Healthcare Marketing Into a New Era: Looking Ahead to 2026

As 2025 closes, EVERSANA INTOUCH leaders were featured in Med Ad News’ annual Healthcare Agency Roundup. They shared their insights on how trends are shaping the industry both today and tomorrow and noted how healthcare marketing is entering a transformative era driven by trust, technology and authenticity. Read the blog to learn more.

12|04|25

Insights from Frontiers Health: Innovation, Transformation & the Power of Data

At Frontiers Health Conference in Berlin, Ann Cave, President, Full Service Agencies, shared compelling perspectives on how innovation and data-driven strategies are reshaping patient care. Read her takeaways in this blog.

12|01|25

The Oncologist’s Next Ally: Why Cancer Is Forging the Future of Clinical AI

Cancer care is driving the next wave of clinical AI innovation. In this POV, Barry Vucsko reveals why oncology stands as the ultimate testing ground for technologies poised to transform the entire healthcare ecosystem. For pharma marketers, understanding these seismic shifts isn’t just valuable—it’s vital for staying ahead of the curve.

11|21|25

The Creator Economy Isn’t the Future. It’s the Now. Lessons from Adobe MAX 2025

The Adobe MAX 2025 conference was a fever dream of creative energy: designers, filmmakers, coders, influencers and brands all colliding in a single, humming ecosystem. But the biggest revelation wasn’t an in-development product demo (what they call “Sneaks”) or an AI announcement. It was that the center of creative gravity has shifted. Influence is no […]